Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Case Rep. 2013 May 17;14:157-160. Print 2013.

Acute mono-megakaryoblastic leukemia associated with extreme thrombocytosis and complex karyotype abnormalities.

Author information

  • 1Department of Hematology, Shengjing Hospital, China Medical University, Liaoning, China.

Abstract

Patient: Female, 55 Final Diagnosis: Acute leukemia Symptoms: Thrombocytosis Medication: Idarubicin HCl (Zavedos), Pfizer Clinical Procedure: - Specialty: Hematology.

OBJECTIVE:

Adverse effect of drug therapy.

BACKGROUND:

Thrombocytosis is usually seen in myeloproliferative disorders (MPD) and seldom in acute myeloid leukemias (AML). In acute megakaryoblastic leukemia, platelet counts might exceed 1000×109/L in approximately 30% of patients, while others are frequently presented by cytopenias. To our best knowledge there is no report in the literature on acute mono-megakaryoblastic leukemia, especially with extreme thrombocytosis and complex karyotype abnormalities.

CASE REPORT:

We present the case of a 55-year-old woman with acute mono-megakaryoblastic leukemia with extreme thrombocytosis (greater than 2000×109/L) and complex karyotype abnormalities. The patient was first treated with anti-aggregate therapy and later the patient was put on a regimen consisting of idarubicin 10 mg/m2 daily for 3 days and 200 mg Cytosar daily for 7 days. However, a severe pancytopenia occurred at the first day after chemotherapy and the patient died from intracranial hemorrhage.

CONCLUSIONS:

Extreme thrombocytosis and complex karyotype abnormalities in acute mono-megakaryoblastic leukemia are associated with poor outcome.

KEYWORDS:

acute leukemia; karyotype abnormalities; thrombocytosis

PMID:
23826456
[PubMed - as supplied by publisher]
PMCID:
PMC3700456
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk